Literature DB >> 26913870

History of Diabetes Insipidus.

Giovanna Valenti, Grazia Tamma.   

Abstract

Under physiological conditions, fluid and electrolyte homoeostasis is maintained by the kidney adjusting urine volume and composition according to body needs. Diabetes Insipidus is a complex and heterogeneous clinical syndrome affecting water balance and characterized by constant diuresis, resulting in large volumes of dilute urine. With respect to the similarly named Diabetes Mellitus, a disease already known in ancient Egypt, Greece and Asia, Diabetes Insipidus has been described several thousand years later. In 1670s Thomas Willis, noted the difference in taste of urine from polyuric subjects compared with healthy individuals and started the differentiation of Diabetes Mellitus from the more rare entity of Diabetes Insipidus. In 1794, Johann Peter Frank described polyuric patients excreting nonsaccharine urine and introduced the term of Diabetes Insipidus. An hystorical milestone was the in 1913, when Farini successfully used posterior pituitary extracts to treat Diabetes Insipidus. Until 1920s the available evidence indicated Diabetes Insipidus as a disorder of the pituitary gland. In the early 1928, De Lange first observed that some patients with Diabetes Insipidus did not respond to posterior pituitary extracts and subsequently Forssman and Waring in 1945 established that the kidney had a critical role for these forms of Diabetes Insipidus resistant to this treatment. In 1947 Williams and Henry introduced the term Nephrogenic Diabetes Insipidus for the congenital syndrome characterized by polyuria and renal concentrating defect resistant to vasopressin. In 1955, du Vigneaud received the 1955 Nobel Prize in chemistry for the first synthesis of the hormone vasopressin representing a milestone for the treatment of Central Diabetes Insipidus.

Entities:  

Mesh:

Year:  2016        PMID: 26913870

Source DB:  PubMed          Journal:  G Ital Nefrol        ISSN: 0393-5590


  6 in total

1.  A 4-year-old boy presenting with persistent urinary incontinence: Answers.

Authors:  Werner Keenswijk; Johan Vande Walle
Journal:  Pediatr Nephrol       Date:  2016-06-27       Impact factor: 3.714

Review 2.  The Emerging Role of Copeptin.

Authors:  R Jalleh; D J Torpy
Journal:  Clin Biochem Rev       Date:  2021-02

3.  A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 : A protocol for mixed treatment comparisons meta-analysis.

Authors:  Nie Zhang; Zhi-Qun Gu; Yun-Long Ding; Liu Yang; Mao-Bing Chen; Qi-Han Zheng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 4.  Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Authors:  Xin Yi Yeo; Grace Cunliffe; Roger C Ho; Su Seong Lee; Sangyong Jung
Journal:  Biomedicines       Date:  2022-02-01

5.  Analysis on Value of Continuous Nursing Based on WeChat in Improving Healthy Quality of Life and Self-Management Behavior of Patients with Diabetic Nephropathy.

Authors:  Liu Li; Haiyan Chen; Can Peng; Li Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-21       Impact factor: 2.650

Review 6.  Drug rechanneling: A novel paradigm for cancer treatment.

Authors:  Itishree Kaushik; Sharavan Ramachandran; Sahdeo Prasad; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2020-05-11       Impact factor: 15.707

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.